2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Rigetti Computing appointed David Rivas to the newly created role of Chief Operating Officer and Andrew Bestwick as Chief Technology Officer, both effective August 18, 2026. The company said the changes create a dedicated systems delivery organization to handle deployments and support, while engineering focuses on processor development and its roadmap.
David Rivas, previously Chief Technology Officer, became Chief Operating Officer; his annual base salary was increased to $440,000.
Andrew Bestwick, previously Senior Vice President, Quantum Systems since January 2024, was appointed Chief Technology Officer.
Both executives report to President and CEO Dr. Subodh Kulkarni; the filing states the appointments are effective August 18, 2026.
Astrotech filed a prospectus supplement on August 19, 2026 for an at-the-market offering of up to $50 million of common stock through H.C. Wainwright & Co., replacing the earlier supplement dated June 3, 2026. As of August 19, 2026, the company had sold 258,856 shares for gross proceeds of about $7.9 million under the prior program, and no further sales will be made under it. Because new share sales can dilute existing holders, the filing expands the company's ability to raise equity capital from the market.
New prospectus supplement filed August 19, 2026 covers up to $50 million of common stock sales through H.C. Wainwright & Co.
Prior program allowed up to about $24.5 million; as of August 19, 2026, 258,856 shares sold for gross proceeds of about $7.9 million before commissions and expenses
Offering uses shelf registration Form S-3 (File No. 333-297144), declared effective July 7, 2026
Exhibit 5.1 is a legal opinion from Haynes and Boone, LLP on the shares offered
On August 17, 2026, Unity's Compensation Committee approved a special award of 880,000 performance-based restricted stock units to CEO Matthew Bromberg. The units vest in three tranches only if Bromberg stays CEO through 2027, 2028 and 2029 and the stock meets $50, $60 and $75 price hurdles, so shareholders bear dilution risk only if those price targets are reached.
Award of 880,000 PPSUs to CEO Matthew Bromberg approved August 17, 2026, under the 2020 Equity Incentive Plan
Three tranches of about one-third each, with stock price hurdles of $50.00, $60.00 and $75.00 on the NYSE (30 consecutive days VWAP)
Continued service required through August 17, 2027, 2028 and 2029; performance period runs to August 17, 2031
Unvested units are forfeited on most terminations, with exceptions for termination without Cause, death or disability, and change in control
Silo Pharma entered into an asset purchase agreement on August 18, 2026, to acquire software, technology, domain names and related intellectual property from Parkview Consulting LLC, paying with 165,000 newly issued common shares. The seller's sole member, Corwin Yu, currently serves as lead strategic advisor on the company's Cryptocurrency Advisory Board, a relationship the filing discloses. The shares are locked up for up to 12 months, and the seller gives indemnification protections.
Consideration: 165,000 shares of common stock, par value $0.0001 per share, issued to Parkview Consulting LLC
Lock-up runs until the earliest of 12 months, a Change in Control, or company written consent
Seller is owned by Corwin Yu, who is lead strategic advisor on the Cryptocurrency Advisory Board
Shares issued under Section 4(a)(2) of the Securities Act of 1933; agreement filed as Exhibit 10.1 with schedules omitted
Sera Prognostics appointed Scott Gleason as Chief Financial Officer and Treasurer effective August 31, 2026, replacing Austin Aerts, who steps down from the role on the same date. Aerts will move to an advisory role and a consulting agreement, and Gleason receives a $400,000 base salary and a $500,000 initial equity award, subject to Board approval.
Scott Gleason, 47, becomes CFO and Treasurer effective August 31, 2026, after the board appointment on August 14, 2026.
Gleason's employment agreement sets a $400,000 base salary and a target bonus of 40% of base salary, pro-rated for 2026.
Austin Aerts receives nine months of base salary continuation totaling $354,921.75 and a consulting role at $375 per hour, for a term of twelve months from September 8, 2026.
Gleason's agreement provides twelve months of base salary and target bonus in a lump sum, plus full equity acceleration, if terminated without Cause within three months before or twelve months after a Change in Control.
On August 17, 2026, Nocera entered an employment agreement naming Shun-Chih Chuang Chief Financial Officer for an initial two-year term, with an annual salary of $84,000 and 100,000 company shares per year. The same day, the company signed a two-year consulting agreement with Chien-Hua Tseng for AI module strategy, with share grants that add to the company's common stock.
Shun-Chih Chuang becomes Chief Financial Officer under an employment agreement effective August 17, 2026, with an initial two-year term and an annual salary of $84,000 paid monthly.
The first 100,000 shares were issued to Chuang on execution; a second 100,000 shares are due at the start of the second year. The shares are unregistered and subject to transfer restrictions.
Chien-Hua Tseng's consulting agreement runs through August 16, 2028; 50,000 shares were issued on August 17, 2026, and 50,000 more are issuable on August 17, 2027 only if services continue.
Korn Ferry signed an amended and restated credit agreement on August 18, 2026, adding a $600 million senior secured term loan and keeping its $850 million revolving credit facility, both maturing five years from the effective date. The company used the term loan to fully repay its $400 million 4.625% Senior Notes due 2027 and plans to use the remaining proceeds toward its pending acquisition of AMS. The filing shows new debt that is secured by substantially all company and guarantor assets, a financing step tied to a pending acquisition.
Term loan facility of $600 million; existing $850 million revolving credit facility continued
Interest at Term SOFR plus 1.125% to 2.00%, or base rate plus 0.125% to 1.00%, based on consolidated net leverage ratio
$400 million 4.625% Senior Notes due 2027 redeemed in full on August 18, 2026 at 100% of principal plus accrued interest
Remaining term loan proceeds intended to help fund the pending AMS acquisition
Laird Superfood's board appointed Matthew Spanjers as a director effective August 13, 2026, and placed him on the compensation committee. He is deemed a designee of the Investor affiliated with Nexus Capital Management under a December 21, 2025 Investment Agreement, which gives the investor group a role in his appointment.
Matthew Spanjers appointed director effective August 13, 2026, serving until the next annual meeting
Appointed to the board's compensation committee
Deemed a designee of the Investor (Gateway Superfood affiliates of Nexus Capital Management) under the December 21, 2025 Investment Agreement
Will receive non-employee director cash compensation and option grants on the same terms as other 2026 non-employee director grants
AVAX One Technology's Chief Financial Officer, Chris Polimeni, resigned effective August 17, 2026, and will stay on as a financial consultant through December 31, 2026. The company said there was no disagreement with him over operations, policies or practices. Stephanie Brady, previously Corporate Controller, was appointed Chief Accounting Officer and primary financial officer on August 19, 2026, so shareholders will see a change in the executive overseeing financial reporting while the company is also searching for a permanent CEO.
Chris Polimeni resigned as CFO effective August 17, 2026, and will remain as a financial consultant through December 31, 2026
Stephanie Brady, age 57, was appointed Chief Accounting Officer and primary financial officer on August 19, 2026; she had been Corporate Controller since January 2026
Brady will receive a total payment of $20,000 per month plus incentive compensation tied to timely filing of financial statements
Interim CEO Peter Wylie Jr. will support the finance organization; the Board's search for a permanent CEO continues with ZRG Partners
Two TXNM Energy subsidiaries raised debt in private placements on August 19, 2026. PNM sold $200.0 million of senior unsecured notes, and TNMP issued $150 million of first mortgage bonds in two series. The filing states the proceeds will repay existing and short-term debt, fund capital expenditures and support general corporate purposes, and it says the Blackstone Infrastructure Partners transaction would not trigger a change-in-control obligation under either set of debt.
PNM sold $200.0 million of senior unsecured notes in Series A ($115.0 million, 5.44%, due 2029), Series B ($50.0 million, 5.82%, due 2034) and Series C ($35.0 million, 6.12%, due 2038)
TNMP issued $75,000,000 of 5.23% first mortgage bonds due September 1, 2031 and $75,000,000 of 5.46% bonds due September 1, 2033
Both debt issues include a debt-to-capitalization covenant of 65% or less, and interest is paid semiannually beginning in 2027
The filing states the proposed Blackstone Infrastructure Partners transaction would not constitute a change in control under the notes or bonds
OptimumBank Holding Company issued $35.0 million of 7.50% fixed-to-floating rate subordinated notes due September 1, 2036, at 100% of face amount, in a private placement to institutional investors. The company said it will use the net proceeds for general corporate purposes and intends for the notes to qualify as Tier 2 capital, which adds $35.0 million of unsecured debt that ranks below its senior indebtedness.
$35.0 million principal at a fixed 7.50% rate until September 1, 2031, then resetting quarterly to three-month term SOFR plus 340 basis points
Issued at 100% of face amount under a Subordinated Note Purchase Agreement and Indenture dated August 19, 2026, with UMB Bank, National Association as trustee
Notes are unsecured, subordinated and junior in right of payment to current and future senior indebtedness; the company may redeem them on or after September 1, 2031
Registration Rights Agreement requires an exchange offer; the company must pay additional interest to holders if it fails to meet those obligations
Ionic Digital reported second-quarter 2026 revenue of $48.6 million, up 31% from a year earlier, with 90% coming from digital infrastructure leasing. The company swung to a net loss of $35.3 million, driven in part by a $28.2 million non-cash loss on cryptocurrency and a $27.2 million tax provision, and it reaffirmed its full-year 2026 outlook.
Q2 2026 revenue was $48.6 million, up 31% year-over-year; digital infrastructure leasing made up 90% of revenue.
Net loss was $35.3 million, compared with net income of $31.9 million in the prior-year quarter; basic and diluted loss per share was $0.94 versus earnings of $0.85.
Adjusted EBITDA was $37.6 million, compared with $3.8 million a year earlier; the company now excludes cryptocurrency gains and losses from this measure.
Full-year 2026 outlook reaffirmed: total revenue of $190 million to $195 million and Adjusted EBITDA of $137.5 million to $142.5 million.
Nordson reported record fiscal third-quarter 2026 sales of $818 million, up 10% year over year, and diluted EPS of $2.73, up 23%. The company raised its full-year guidance for sales and adjusted earnings, citing backlog up 35% over the prior year.
Q3 net income was $153 million, or $2.73 per diluted share, versus $126 million, or $2.22, a year earlier
Q3 adjusted EPS was a record $3.25, up 19%, excluding a non-cash loss on a minority investment and acquisition-related items
Full-year sales guidance now $3,035 million to $3,075 million; adjusted EPS guidance now $11.80 to $12.00
Management will discuss results on a webcast on August 20, 2026 at 8:30 a.m. Eastern
Coty reported fiscal fourth-quarter 2026 net revenues of $1,269.2 million, up 1% on a reported basis but down 1% like-for-like, with a reported net loss of $144.3 million versus $72.1 million a year earlier. For the full fiscal year, net revenues fell 2% to $5,806.6 million and the reported net loss was $618.0 million. For the first quarter of fiscal 2027, Coty guided to a like-for-like sales decline in the low- to mid-single digits and an adjusted EBITDA decline in the low teens, which points to weaker profit in the near term for shareholders.
Q4 net revenues of $1,269.2 million rose 1% reported and fell 1% like-for-like; reported operating loss was $42.7 million versus $15.5 million operating income a year earlier
Adjusted operating income fell to $39.5 million from $67.7 million, and adjusted EPS was a loss of $0.02 versus a $0.05 loss a year earlier
FY26 reported net loss was $618.0 million; operating cash flow was $537.8 million and free cash flow was $348.2 million
Q1 FY27 outlook: like-for-like revenue down low- to mid-single digits, adjusted EBITDA down low-teens, adjusted EPS of $0.11 to $0.13 per share, and first-half free cash flow above $300 million
Newell Brands issued $600 million of 6.250% senior notes due 2031 on August 19, 2026, in a private offering exempt from US registration. The company plans to use the proceeds to redeem in full its 6.375% senior notes due 2027, pay related fees, and repay part of its asset-based revolving credit facility. The filing describes a refinancing of existing debt, and the new notes add $600 million of senior unsecured obligations.
$600 million aggregate principal of 6.250% senior notes due 2031 issued August 19, 2026
2027 notes to be redeemed at 101.530%, or $1,015.30 per $1,000 principal, plus accrued interest, with a redemption date of August 20, 2026
Proceeds also to repay part of the revolver under a five-year asset-based facility dated July 30, 2026
If a change of control and ratings downgrade occur, the company must offer to repurchase the notes at 101% of principal plus accrued interest
Xcel Brands entered an Equity Distribution Agreement on August 18, 2026, allowing it to sell up to $10 million of common stock through Maxim Group LLC as sales agent. The company will pay Maxim a 3.0% commission on gross sales, and the shares are registered under an existing Form S-3 effective February 6, 2024. Because new shares can dilute existing holders, the agreement matters to shareholders, though the filing does not say whether or when any shares will be sold.
Maximum aggregate offering price of up to $10,000,000 of common stock, par value $0.001 per share
Agent commission of 3.0% of gross sales price of shares sold
Sales may be made at the market on Nasdaq Capital Market or in privately negotiated transactions with prior written approval
Shares registered on Form S-3 (File No. 333-276698), effective February 6, 2024; prospectus supplement dated August 18, 2026
Unifi reported fiscal fourth-quarter 2026 net sales of $144.2 million, up 4.1% from a year earlier, and gross profit of $14.3 million, compared with a gross loss the prior year. The company still posted a net loss of $1.2 million after a year-earlier net profit that included a $35.8 million gain on a facility sale, and full-year sales fell to $531.3 million from $571.3 million. The company also agreed after quarter end to sell non-strategic real estate for $60.0 million, which it says will support debt reduction.
Q4 net sales were $144.2 million, up from $138.5 million, led by Brazil, while Americas and Asia were softer.
Q4 net loss was $1.2 million, or $0.06 per share, versus net income of $15.5 million, or $0.82 per share, in the prior-year quarter that included a $35.8 million gain.
Adjusted EBITDA was $8.2 million, compared with $(4.1) million in the prior-year quarter.
Fiscal 2026 net loss was $24.6 million, or $1.33 per share, and operating cash flow was $26.5 million; a $60.0 million real estate sale agreement was signed after the quarter.
On August 18, 2026, Griffon completed an $800 million private offering of 6.25% senior notes due October 1, 2034, with net proceeds of approximately $792 million. The same day it entered a Third Amendment that replaces its $500 million revolving credit facility and extends that facility's maturity to August 18, 2031. The filing adds new long-term debt and secured borrowing terms, which shareholders should weigh against the company's existing obligations.
Notes: $800 million principal, 6.25% annual interest paid semi-annually, maturing October 1, 2034; net proceeds about $792 million.
Revolving credit facility: $500 million, maturity extended to August 18, 2031; initial Term SOFR margin of 1.75%.
Revolver is secured by liens on substantially all assets of the company and guarantors; maintenance tests include a maximum 5.50 to 1.00 consolidated leverage ratio.
Bank of America, N.A. is administrative agent for the credit agreement; BofA Securities was representative of the notes initial purchasers.
Granite Ridge Resources appointed John Cocke and Jonathan Adams to its board, expanding it from seven to nine directors, after Grey Rock affiliates distributed 14,000,000 shares to their limited partners. Because Grey Rock and its affiliates now hold about 39% of the stock, the company is no longer a controlled company under NYSE rules, and the board says it is now majority independent.
Grey Rock affiliates distributed 14,000,000 shares of common stock to limited partners on August 19, 2026, and now own about 39% of outstanding shares.
The company ceased to be a controlled company under NYSE rules and expects to complete its governance transition within NYSE phase-in periods.
John Cocke (Class II, term to 2027 annual meeting) and Jonathan Adams (Class III, term to 2028 annual meeting) joined the board effective August 19, 2026.
Each new director received 19,305 common shares and 5,315 restricted shares, with the restricted shares vesting in full on January 2, 2027. The company received no proceeds from the distribution.
Harte Hanks signed a definitive merger agreement under which Star Equity Holdings will acquire all outstanding Harte Hanks common stock for $5.00 per share, or $38.4 million in aggregate equity value. The Harte Hanks board unanimously approved the deal and recommends that shareholders vote in favor, and the transaction is expected to close within about 60 to 90 days, subject to shareholder approval and financing availability.
Each Harte Hanks share can be exchanged for $5.00 in cash, subject to a cap of 50% of total consideration (about $19.2 million), or 0.50 shares of Star Equity 10% Series A Cumulative Perpetual Preferred Stock (Nasdaq: STRRP) with a $10.00 p
The company describes the price as an approximately 100% premium to its unaffected share price.
A 30-day go-shop period allows Harte Hanks to solicit alternative proposals and expires at 11:59 p.m. Eastern Time on September 13, 2026.
Citizens Capital Markets & Advisory is lead financial advisor and Baker Botts LLP is legal advisor to Harte Hanks.
John B. Sanfilippo & Son reported fiscal 2026 fourth-quarter diluted EPS of $0.71, down 38.3%, even though net sales rose 4.2% to $280.4 million. Higher input and transportation costs, a $2.7 million recall-related cost and other factors weighed on gross profit, while full-year net sales rose 6.2% to $1.18 billion and full-year diluted EPS rose 4.6% to $5.26. The company also said CEO Jeffrey T. Sanfilippo will step down in October to become Executive Chairman, with his brother Jasper succeeding him as CEO.
Q4 net sales rose 4.2% to $280.4 million, but gross margin fell to 15.7% from 18.1% and diluted EPS fell 38.3% to $0.71.
Full-year net sales rose 6.2% to $1.18 billion and diluted EPS rose 4.6% to $5.26; sales volume fell 2.5%.
Annual dividend declared was raised 5.6% to $0.95 per share, plus a special dividend of $1.05 per share, both payable September 9, 2026.
Jeffrey T. Sanfilippo steps down as CEO in October; Jasper Sanfilippo will succeed him.
Peoples Financial Services Corp. (PFIS) furnished a 2026 Q2 investor presentation as Exhibit 99.1 to an 8-K, for use in investor meetings during 2026. The presentation reports Q2 2026 net income of $14.8 million, or $1.48 per diluted share, compared with $1.47 in Q1 2026, and tangible book value per share of $43.51, up $1.22 from the prior quarter.
Q2 2026 net income of $14.8 million, or $1.48 per diluted share, versus $1.47 in Q1 2026
ROATCE of 13.7%, net interest margin (FTE) of 3.82%, and efficiency ratio of 55.2% for Q2 2026
Nonperforming loans to total loans rose to 0.33% at June 30, 2026, from 0.28% at March 31, 2026
Tangible book value per share of $43.51 at June 30, 2026, up $1.22 quarter over quarter
Ameresco said its Chief Financial Officer and Chief Accounting Officer, Mark Chiplock, will resign effective September 25, 2026, to take a CFO role at a private equity-owned company in a different industry. The company said the departure was not the result of any disagreement on its operations, policies or practices, and it has started a search for a successor. The company also reiterated its full-year 2026 guidance, which matters to shareholders because it gives no sign of a change in the outlook alongside the leadership change.
Mark A. Chiplock resigned as EVP, CFO and Chief Accounting Officer; the company received notice on August 17, 2026, and the resignation is effective September 25, 2026.
Chiplock will remain CFO through September 25, 2026, to support an orderly transition.
Full-year 2026 guidance reiterated: revenue of $2.0 billion to $2.2 billion, Adjusted EBITDA of $250 million to $270 million, and Non-GAAP EPS of $1.15 to $1.35.
The company has begun a search for its next Chief Financial Officer.
Aurinia Pharmaceuticals said it has settled patent infringement litigation with Teva Pharmaceuticals over Teva's application to sell a generic 7.9 mg voclosporin capsule in the United States. Under the settlement, Teva has stipulated that Aurinia's two U.S. patents are enforceable, valid and would be infringed, and Teva may launch no earlier than December 7, 2036, subject to earlier contingencies and FDA approval. The filing gives no financial figures, and Aurinia's other patent actions continue.
Teva stipulated that U.S. Patent Nos. 10,286,036 and 11,622,991 are enforceable, valid and would be infringed, and that the patents expire in December 2037.
Teva may launch its generic voclosporin no earlier than December 7, 2036, unless defined contingencies occur earlier.
Teva's U.S. launch also depends on FDA approval of its generic product.
Aurinia's patent infringement actions against five other companies continue in the U.S. District Court for the District of New Jersey.
Vogenx, Inc. closed the full exercise of the underwriter's over-allotment option on August 19, 2026, selling 937,500 additional shares at $13.00 each. Including these shares, the initial public offering totals 7,187,500 shares and about $93.4 million in gross proceeds before underwriting discounts, commissions and offering expenses.
The IPO initially closed on August 13, 2026, with 6,250,000 shares sold at $13.00 per share for $81.25 million in gross proceeds.
The over-allotment closing on August 19, 2026 added about $12.19 million in gross proceeds.
Total shares sold in the offering rose to 7,187,500, with JonesTrading Institutional Services LLC as underwriter.
Science Applications International Corporation entered into Amendment No. 6 to its Master Accounts Receivable Purchase Agreement with MUFG Bank, Ltd. on August 14, 2026. The amendment raises the facility limit for selling eligible U.S. government receivables from $300 million to $400 million, with other terms unchanged. The change expands the company's receivables financing capacity, but the filing does not describe any financial results or effect on earnings.
Amendment No. 6 dated August 14, 2026, with MUFG Bank, Ltd. as purchaser
Facility limit for sale of designated eligible U.S. government receivables increased to $400 million from $300 million
Remaining material terms of the existing purchase agreement are unchanged
Filed as Exhibit 10.1 with the 8-K dated August 19, 2026
The Metals Company said the National Oceanic and Atmospheric Administration published its consolidated application for an exploration license and commercial recovery permit for the TMC USA-A area in the Federal Register. The publication starts a public comment period that NOAA views as a prerequisite to certification, and NOAA still has to certify the application, complete an environmental review, and make a final licensing decision.
NOAA published the TMC USA-A consolidated application in the Federal Register; NOAA had determined the application fully compliant on April 28, 2026.
The application covers a proposed exploration and commercial recovery area of about 65,000 square kilometers, up from about 25,000 square kilometers in the April 2025 applications, with an estimated 619 million tonnes of wet nodules and pot
Remaining steps include certification, an environmental review with a draft Environmental Impact Statement for public comment, and a final determination on the license and permit.
The filing does not state a financial result, guidance change or timeline for a final NOAA decision.
BILL reported fourth-quarter fiscal 2026 total revenue of $436.2 million, up 14% year-over-year, but its GAAP net loss widened to $18.5 million from $7.1 million a year earlier, including a $76.6 million restructuring charge. Non-GAAP operating income rose 80% to $101.6 million. The company guided fiscal 2027 total revenue to $1,807.0 million to $1,857.0 million and plans to net rewards expense from revenue starting with the quarter ending September 30, 2026, which will change how its reported revenue is presented.
Q4 total revenue was $436.2 million, up 14%; core revenue was $400.5 million, up 16%.
Q4 GAAP net loss was $18.5 million, or $0.19 per share, versus a net loss of $7.1 million, or $0.07 per share, a year earlier.
Q4 restructuring expense was $76.6 million; non-GAAP operating income was $101.6 million, up 80%.
FY27 guidance: total revenue of $1,807.0 million to $1,857.0 million (9% to 12% growth) and non-GAAP net income per diluted share of $3.56 to $3.79.
Carlyle Credit Income Fund reported third quarter 2026 results for the quarter ended June 30, 2026. Total investment income fell to $4.3 million from $5.5 million in the prior quarter, and net investment income fell to $1.5 million, or $0.07 per common share, from $0.09. The fund swung to a net income of $3.5 million from a net loss of $33.0 million in the prior quarter, and its net asset value per common share was $3.32, versus $3.34 at March 31, 2026.
Net investment income was $0.07 per common share in the quarter, versus $0.09 in the prior quarter and $0.19 a year earlier.
Total investment income was $4.3 million, down from $5.5 million in the prior quarter and $8.6 million in the third quarter of 2025.
The fund declared monthly common dividends of $0.06 per share for September, October and November 2026, unchanged from the prior quarter.
The fund will hold a conference call at 10:00 a.m. EDT on August 20, 2026.
Trio-Tech International said its common stock has been approved for listing on the Nasdaq Global Market, moving from the NYSE American. The stock will keep the ticker TRT, with Nasdaq trading expected to begin at the open on September 16, 2026, and NYSE trading ending at the close on September 15, 2026. The filing describes a listing transfer and includes no financial results or guidance.
Common stock moves from the NYSE American to the Nasdaq Global Market; the ticker stays TRT
Nasdaq listing expected to begin at the opening of trading on or about September 16, 2026
NYSE American trading ends at the close of September 15, 2026
CEO S.W. Yong said the company believes Nasdaq will broaden institutional investor awareness and visibility
ZeroStack agreed on August 19, 2026 to issue 3,500,000 common shares and pre-funded warrants for up to 36,198,293 additional shares to two investors, Puple AI Inc. and Blockcat Pte. Ltd., in exchange for 925,925,926 MemeCore tokens valued at about $1 billion. Shares beyond a 19.99% cap will be issued as warrants that cannot be exercised until shareholders approve, and the company named Rudy Rong, a source of the tokens, as President. The deal adds a large number of potential shares, which would dilute existing shareholders, while the company says the share price represents a premium of more than twelve times its recent trading price.
Investors receive 3,500,000 shares plus pre-funded warrants for up to 36,198,293 more shares, valued at $25.19 per share or warrant.
MemeCore tokens were valued at $1.08 each as of August 14, 2026, for aggregate consideration of about $1 billion.
Warrant shares cannot be exercised until shareholder approval under Nasdaq Listing Rule 5635, and they carry a lock-up of up to ten years.
Rudy Rong was appointed President effective at closing, with a $500,000 annual base salary and severance of 24 months of base pay, or 30 months after a change in control.
TJX reported second-quarter fiscal 2027 net sales of $15.2 billion, up 5%, with comparable sales up 4% and diluted earnings per share of $1.36, up 24% from $1.10. The company raised its full-year fiscal 2027 pretax profit margin and diluted EPS outlook, to $5.31 to $5.36 per share. Q2 results include a net benefit from IEEPA tariff refunds, so adjusted diluted EPS was $1.22, up 11%.
Q2 net sales $15.2 billion, up 5%; comparable sales up 4%, with Marmaxx at +1% and HomeGoods at +7%
Q2 diluted EPS $1.36 vs. $1.10 a year earlier; adjusted diluted EPS $1.22 excluding a $.14 net tariff refund benefit
Full-year fiscal 2027 diluted EPS outlook raised to $5.31 to $5.36; adjusted outlook $5.15 to $5.20
Returned $1.3 billion to shareholders in Q2 through buybacks ($798 million) and dividends ($529 million)
Progressive reported July 2026 net income of $961 million, down 12% from $1.09 billion a year earlier, with earnings of $1.65 per share versus $1.85. Net premiums written rose 5% to $7.4 billion, but the combined ratio worsened to 86.8 from 85.3, and the company recorded pretax realized losses on securities of $47 million compared with gains of $79 million a year earlier. Year-to-date net income rose to $7.09 billion from $6.83 billion.
July net premiums written were $7.4 billion, up 5%; net premiums earned were $7.4 billion, also up 5%.
The July combined ratio was 86.8, up 1.5 points from 85.3 a year earlier.
July pretax net realized losses on securities were $47 million, compared with gains of $79 million in July 2025.
Policies in force reached 40.3 million at July 31, 2026, up 7% from a year earlier; August results are due September 18, 2026.
Lowe's reported second-quarter 2026 net earnings of $2.4 billion and diluted EPS of $4.27, flat from a year earlier, while total sales rose to $26.0 billion from $24.0 billion. The company lowered the top end of its fiscal 2026 diluted EPS and comparable sales outlook, which matters to shareholders because the forecast now points to flat comparable sales and a narrower earnings range.
Q2 diluted EPS was $4.27, the same as the prior-year quarter; adjusted diluted EPS rose 1.6% to $4.40 from $4.33.
Q2 comparable sales rose 0.2%, and online sales grew 15.7%; total sales were $26.0 billion versus $24.0 billion.
Fiscal 2026 diluted EPS is now about $11.75 (previously $11.75 to $12.25); adjusted diluted EPS is about $12.25 (previously $12.25 to $12.75).
Q2 EPS included an $0.11 benefit from IEEPA tariff refunds, and $96 million in pre-tax acquisition-related expenses.
Envista's board named President and CEO Paul Keel as Chair of the Board, effective August 19, 2026, succeeding Scott Huennekens, who becomes Lead Independent Director. The Compensation Committee also approved a $200,000 base salary increase for Keel and a one-time equity award valued at $10 million, plus a $1.5 million PSU award for CFO Eric Hammes, tied to four-year relative total stockholder return.
Paul Keel, President and CEO since joining in May 2024, becomes Chair of the Board effective August 19, 2026
Keel's base salary rises $200,000, from $1.1 million to $1.3 million per year, effective August 24, 2026
Keel's one-time equity award totals $10 million: $5 million in time-based RSUs and $5 million in PSUs at target
CFO Eric Hammes received a special PSU award valued at $1.5 million, granted August 18, 2026
Playtika's controlling shareholder told the company on August 18, 2026 that China's National Development and Reform Commission approved a request for the company to issue bonds of up to $800 million. The proceeds would be used to prepay part of the principal on the company's outstanding term loan under its December 10, 2019 credit agreement. The approval expires July 30, 2027 and remains subject to the procedures under China's foreign debt rules.
NDRC approved bond issuance of up to $800 million, announced August 18, 2026
Bond proceeds would prepay a portion of the outstanding term loan under the December 10, 2019 Credit Agreement
Approval expires July 30, 2027 and is subject to the Foreign Debt Rules procedures
Marvell Technology entered a commercial agreement with Google on July 29, 2026, covering custom semiconductor products that attach to Google's TPU ecosystem. On August 18, 2026, Marvell issued Google a warrant to buy up to 58,970,907 shares at $206.58 per share, with most shares vesting as Google's purchases of custom products grow. For shareholders, the deal links a large customer relationship to potential share issuance that could dilute existing holders.
July 29, 2026: Marvell and Google signed a commercial agreement covering AI inference accelerators, storage controllers, network interface controllers, memory interface controllers and near-memory compute.
August 18, 2026: Marvell issued Google a warrant to purchase up to 58,970,907 shares of common stock at $206.58 per share, exercisable until August 18, 2033.
1,360,867 warrant shares vest in equal quarterly installments during the first year; the remaining shares vest in 240 tranches, one for each $500 million in Custom Products revenue from Google and its affiliates.
The warrant was issued under the Section 4(a)(2) registration exemption; Google has customary registration rights for the warrant shares.
Honeywell announced leadership changes effective October 1, 2026: Billal Hammoud, currently CEO of Building Automation, will lead Process Technology, and Juan Picon will succeed him at Building Automation. Ken West, current CEO of Process Technology, will leave the company on August 31, 2026, to pursue an external opportunity. The filing contains no financial results or guidance, so the changes are management reshuffles rather than a direct measure of performance.
Billal Hammoud, age 54, to become President and CEO of Process Technology effective October 1, 2026
Juan Picon, age 57, to succeed Hammoud as President and CEO of Building Automation effective October 1, 2026
Ken West, age 49, current Process Technology CEO, departs August 31, 2026
Baxter International appointed John Rogers, formerly CFO of Smith+Nephew, as executive vice president and chief financial officer, effective October 1, 2026. Anita Zielinski, interim CFO and chief accounting officer, departs September 15, 2026, and CEO Andrew Hider will serve as interim CFO until Rogers starts. The company also reiterated its full-year 2026 outlook from its July 30, 2026 earnings announcement.
Rogers base salary is $925,000, with a target annual bonus of 100% of base salary and a $4,000,000 target annual equity grant value starting with the 2027 grant.
Rogers receives a $2,827,629 sign-on bonus, subject to repayment if he leaves within 12 months of his start date, or 50% if he leaves within 12 to 24 months.
Andrew Hider serves as interim CFO from September 15, 2026 until October 1, 2026, with no additional compensation for that role.
Bernie Heine was named interim chief accounting officer and controller effective September 15, 2026, with a $15,000 monthly payment and a $250,000 grant-date value equity award.
United Community Banks, Inc. said Tom Speir will succeed Jefferson L. Harralson as Chief Financial Officer effective September 8, 2026. Harralson will remain employed through December 31, 2026 to support an orderly transition, and the filing sets out Speir's pay package.
Tom Speir, age 44, most recently served as Head of Investor Relations, Strategy and Corporate Development at Regions Financial Corp.
Base salary of $600,000, annual target bonus of 80% of base salary, and sign-on bonus of $215,000
Sign-on equity grant valued at $450,000, vesting 50% per year over 2 years
Jefferson L. Harralson remains employed through December 31, 2026 to support the transition
Core Natural Resources said its board appointed Nathan Tucker as senior vice president and chief financial officer, effective immediately, succeeding Mitesh Thakkar in that role. Thakkar remains president and takes on day-to-day responsibility for operations, marketing, logistics, and long-term strategy. The filing describes the changes as part of the company's long-term succession process and discloses Tucker's new pay terms, but it includes no financial results.
Board appointed Nathan Tucker as SVP and CFO on August 18, 2026, effective immediately
Tucker's annual base salary increased to $400,000, with target short-term incentive at 65% and long-term incentive at 125% of base salary
Mitesh Thakkar continues as president, with day-to-day responsibility for operations, marketing, logistics, and long-term strategy
Tucker has been Core's vice president of finance since the company's formation in January 2025
3M Company entered a new $4.25 billion unsecured revolving credit facility on August 17, 2026, replacing its former $4.25 billion revolving credit agreement, which was terminated on the same date. The facility matures on the fifth anniversary of the effective date and gives 3M a standby borrowing source, with pricing tied to its credit rating and covenants including a minimum EBITDA to interest ratio of 3.0 to 1.0.
New $4.25 billion unsecured revolving facility, effective August 17, 2026, with JPMorgan Chase Bank, N.A. as administrative agent
Facility matures five years after the effective date; the former $4.25 billion agreement dated May 11, 2023 was terminated on the same date
Interest margins range from 0.625% to 1.125% for Term SOFR and EURIBO borrowings; commitment fee ranges from 0.05% to 0.11% per annum
Covenant requires an EBITDA to Interest Ratio of at least 3.0 to 1.0; lenders may demand prepayment on a change of control with 30 days' notice
Estée Lauder reported fiscal 2026 results for the year ended June 30, 2026, with net sales up 5% to $15.0 billion and diluted earnings of $0.50 per share, compared with a loss of $3.15 per share a year earlier, which included large impairment charges. The company affirmed its fiscal 2027 organic net sales growth outlook of 3% to 5% and raised its adjusted operating margin outlook to 12.7% to 13.5%.
Full-year net sales were $15.0 billion, up 5% as reported and up 3% organically.
Diluted earnings were $0.50 per share, versus a loss of $3.15 per share in fiscal 2025; adjusted diluted earnings were $2.51, up from $1.51.
Fiscal 2027 outlook: organic net sales growth of 3% to 5% affirmed; adjusted operating margin outlook raised to 12.7% to 13.5%.
Free cash flow was $1.32 billion, compared with $0.67 billion in the prior year.
Mereo BioPharma Group plc was told by Nasdaq that it has not yet regained the $1.00 minimum bid price required for continued listing, but it qualifies for an additional 180-day period, running to February 16, 2027. The notice has no immediate effect on the listing of its American Depositary Shares, though a failure to regain compliance by then would lead to a delisting notice that the company could appeal.
Nasdaq's first notice, dated February 17, 2026, set an initial compliance deadline of August 17, 2026.
On August 18, 2026, Nasdaq issued a second notice granting an additional 180 calendar days, until February 16, 2027.
Regaining compliance requires a closing bid price of at least $1.00 per share for 10 consecutive business days.
The company says the listing is unaffected for now and that it may consider options to regain compliance.
Target reported second-quarter 2026 net sales of $26.5 billion, up 5.3 percent, and diluted EPS of $4.11 versus $2.05 a year earlier. The results include a $994 million tariff refund benefit worth $1.65 per share, and excluding refunds EPS rose 20 percent. Target raised its full-year 2026 net sales growth outlook to around 5 percent and set a full-year EPS range of $9.90 to $10.90, which includes the refund benefit.
Q2 net sales of $26.5 billion rose 5.3 percent; comparable sales grew 3.8 percent, with digital comparable sales up 8.7 percent.
Q2 operating income was $2.6 billion versus $1.3 billion last year, including the $994 million tariff refund benefit.
Full-year 2026 EPS guidance is $9.90 to $10.90, including about $1.65 of Q2 tariff refund benefit; the company excludes potential future refunds from guidance.
No stock was repurchased in Q2; about $8.3 billion remained under the repurchase program approved in August 2021.
Stock Yards Bancorp's Board of Directors voted on August 18, 2026, to increase the quarterly cash dividend to $0.33 per common share, payable October 1, 2026, to holders of record as of September 21, 2026. The company says it has raised its dividend 19 times since 2011, a cumulative increase of 175%, which gives shareholders a higher cash payout per share each quarter.
Quarterly cash dividend increased to $0.33 per common share
Payable October 1, 2026, to stockholders of record as of September 21, 2026
Board approved the increase on August 18, 2026; press release issued August 19, 2026
CEO James A. Hillebrand said the company has raised its quarterly dividend 19 times since 2011, a cumulative increase of 175%
On August 17, 2026, MediciNova signed new executive employment agreements with CEO Yuichi Iwaki and Chief Medical Officer Kazuko Matsuda, replacing their prior employment and severance arrangements. The agreements set base salaries, bonus targets and enhanced change-in-control severance, which matters to shareholders because it defines potential future costs tied to these executives.
Dr. Iwaki's base salary is $690,246 with a target bonus of 55% of salary; Dr. Matsuda's base salary is $540,143 with a target bonus of 40%.
Following a change in control, Dr. Iwaki would receive 24 months of base salary plus 24 months of target bonus; Dr. Matsuda would receive 18 months of each.
Without a change in control, involuntary termination pays 12 months of base salary for both executives.
The full agreements will be filed with the Form 10-Q for the quarter ended September 30, 2026.
Analog Devices reported fiscal third-quarter 2026 revenue of $4.02 billion for the quarter ended August 1, 2026, up 40% from $2.88 billion a year earlier, and diluted earnings per share of $2.74 versus $1.04. The company forecast fourth-quarter revenue of $4.3 billion, plus or minus $100 million, and reported EPS of $3.14, plus or minus $0.15, and it declared a $1.10 quarterly dividend.
Q3 revenue $4.02 billion, up 40% from $2.88 billion; operating income $1.61 billion versus $818 million
Diluted EPS $2.74 versus $1.04; adjusted diluted EPS $3.45 versus $2.05
Kiora Pharmaceuticals granted Chong Kun Dang Pharmaceutical Corporation (CKD) an exclusive license to develop and commercialize KIO-301 in South Korea for retinitis pigmentosa and other ophthalmology uses, under an agreement effective August 20, 2026. Kiora will receive a $1.0 million upfront payment, plus eligible milestone payments and double-digit royalties on South Korean net sales, and says the deal completes its global partner network for the product.
CKD pays a $1.0 million upfront payment to Kiora under the Exclusive License and Development Agreement.
Kiora is eligible for clinical, regulatory and sales milestone payments and double-digit royalties on net sales of KIO-301 in South Korea.
CKD will handle development and commercialization in South Korea; Kiora expects its partners Laboratoires Théa, Senju Pharmaceutical and CKD to run a single global Phase 3 trial.
The agreement was announced in a press release dated August 19, 2026, and either party may terminate it upon certain customary events.
EDAP TMS said the underwriters of its August 2026 public offering fully exercised their option to buy 1,263,750 additional American Depositary Shares. The additional shares are expected to close on August 19, 2026, with net proceeds to the company of about $5.6 million before estimated offering expenses.
Underwriters fully exercised the 30-day option on August 14, 2026, for 1,263,750 additional ADSs
Original offering of 8,425,000 ADSs at $4.75 per ADS closed on August 14, 2026
Additional ADS issuance expected to close August 19, 2026, with net proceeds of about $5.6 million
Jones Day opinion on the validity of the shares filed as Exhibit 5.1
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.